Intracellular distribution of HMG1, HMG2 and UBF change following treatment with cisplatin

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1307, Issue 2, 1996, Pages 213-219

  Chao, James C ^b   X Steven, Wan ^b   Engelsberg, Beatrice N ^b   Rothblum, Lawrence I ^a   Billings, Paul C ^b  

^a WEIS CENTER FOR RESEARCH   (United States)

^b UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

3,3 Diaminobenzidine tetrahydrochloride; Cisplatin; Dithiothreitol; Mercaptoethanol

Indexed keywords

MAMMALIA;

CISPLATIN; HIGH MOBILITY GROUP PROTEIN; UNCLASSIFIED DRUG; UPSTREAM BINDING FACTOR;

ARTICLE; CONTROLLED STUDY; DNA DRUG COMPLEX; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CISPLATIN; DNA ADDUCTS; DNA DAMAGE; DNA-BINDING PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; HIGH MOBILITY GROUP PROTEINS; HUMANS; LUNG NEOPLASMS; POL1 TRANSCRIPTION INITIATION COMPLEX PROTEINS; PROTEIN BINDING; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0029942028     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-4781(96)00052-8     Document Type: Article

References (27)

1. Rosenberg, B., Van Camp, L. and Krigas, T. (1965) Nature 205, 698-699.
2. Reed, E. Platinum Analogs. (1993) in Cancer, Principles and Practice of Oncology (DeVita, V.T., Hellman, S. and Rosenberg, S.A., eds.), J.B. Lippincott, Philadelphia, PA. pp. 390-399.
3. Chu, G. (1994) J. Biol Chem. 269, 787-790.
4. Bellon, S.F. and Lippard, S.J. (1990) Biophys. Chem. 35, 179-188.
5. Hanawalt, P.C. (1995) Mutation Res. 336, 101-113.
6. Sancar, A. (1995) J. Biol. Chem. 270, 15915-15918.
7. Hughes, E.N., Engelsberg, B.N. and Billings, P.C. (1992) J. Biol. Chem. 267, 13520-13527.
8. Pil, P.M. and Lippard, S.J. (1992) Science 256, 234-237.
9. Treiber, D.K., Zhai, X.Q., Jantzen, H.M. and Essigmann, J.M. (1994) Proc. Natl. Acad. Sci. USA 91, 5672-5676.
10. Grosschedl, R., Giese, K. and Pagel, J. (1994) Trends in Genetics 10, 94-100.
11. Read, C.M., Cary, P.D., Crane-Robinson, C., Driscoll, P.C., Carrillo, M.O.M. and Norman, D.G. (1995) in F. Eckstein and D.M.J. Lilley, eds. Nucleic Acids and Molecular Biology, vol. 9. Springer, Berlin, pp. 222-250.
12. Jantzen, H., Admon, A., Bell, S.P. and Tijan, R. (1990) Nature 344, 830-836.
13. Sinclair, A.H., Berta, P., Palmer, M.S., Hawkins, J.R., Griffiths, B.L., Smith, M.J., Foster, J.W., Frischauf, A.M., Lovell, B.R. and Goodfellow, P.N. (1990) Nature 346, 240-244.
14. Falciola, L., Murchie, A.I.M., Lilley, D.M.J. and Blanchi, M.E. (1994) Nuc. Acids Res. 22, 285-292.
15. Choi, Y.D. and Dreyfuss, G. (1984) J. Cell Biol. 99, 1997-2004.
16. Smith, S.D., O'Mahony, D.J., Kinsella, B.T. and Rothblum, L.I. (1993) Gene Expression 3, 229-236.
17. Laemmli, U.K. (1970) Nature 227, 680-685.
18. Billings, P.C., Davis, R.J., Engelsberg, B.N., Skov, K.A. and Hughes, E.N. (1992) Biochem. Biophys. Res. Commun. 188, 1286-1294.
19. Harlow, E. and Lane, D. (1988) in Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, pp. 511-552.
20. Abmayr, S.M. and Workman, J.L. (1993) in Current Protocols in Molecular Biology (Ausubel, F. M, et al., eds.), Wiley, New York, pp. 12.1.1-12.1.9.
21. Bhullar, B.S., Hewitt, J. and Candido, E.P. (1981) J. Biol. Chem. 256, 8801-8806.
22. Bustin, M. and Neihart, N.K. (1979) Cell 16, 181-189.
23. Einck, L. and Bustin, M. (1985) Exp. Cell Res. 156, 295-310.
24. Chan, E.K.L., Imai, H., Hamel, J.C. and Tan, E.M. (1991) J. Exp. Med. 174, 1239-1244.
25. Bustin, M., Lehn, D.A. and Landsman, D. (1990) Biochem. Biophys. Acta 1049, 231-243.
26. Sorenson, C.M. and Eastman, A. (1990) J. Natl. Cancer Inst. 82, 749-755.
27. Huang, J.C., Zamble, D.B., Reardon, J.T., Lippard, S.J. and Sancar, A. (1994) Proc. Nat. Acad. Sci. USA 91, 10394-10398.